Antimicrobial susceptibility of viridans group streptococci

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 4, 1997, Pages 277-280

  Tuohy, Marion ^a   Washington, John A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PENICILLIN DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS MILLERI; STREPTOCOCCUS MITIS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; DRUG RESISTANCE, MICROBIAL; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PENICILLINS; RIFAMPIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; THIENAMYCINS; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0031415691     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00140-5     Document Type: Article

References (15)

1. Avada A, van der Auwera P, Meunier F, Daneau D, Klastersky J (1992) Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15:33-48.
2. Bochud PY, Engiman P, Calandra T, van Melle G, Saghafi L, Francioli P (1994) Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors. Clin Infect Dis 18:25-31.
3. Bourgault A-M, Wilson WR, Washington JA II (1979) Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis 140:316-321.
4. Carratala J, Alcide F, Fernandez-Sevilla A, Corbella X, Linares J, Gudiol F (1995) Bacteremia due to viridans streptococci that are highly resistant to penicillin: Increase among neutropenic patients with cancer. Clin Infect Dis 20:1169-1173.
5. Dajani AS, Taubert KA, Wilson W, et al. (1997) Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Med Assoc 277:1794-1801.
6. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL (1996) Emergence of high rates of resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 40:891-894.
7. Endtz HP, Mouton JW, den Hollander JG, van den Braak N, Verbrugh HA (1997) In vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and other bloodstream infections. Antimicrob Agents Chemother 41:1146-1149.
8. Guio HFL, Corel LJA, Vossen JMJJ (1994) Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haemotological disorders. Eur J Clin Microbiol Infect Dis 13:645-650.
9. McWhinney PHM, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC (1993) Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients. Antimicrob Agents Chemother 37:2493-2495.
10. National Committee for Clinical Laboratory Standards (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 4th edition; Approved Standard. NCCLS Document M7-A4. Wayne, PA: NCCLS.
11. Pfaller MA, Jones RN (1997) In vitro evaluation of contemporary β-lactam drugs tested against viridans group and β-haemolytic streptococci. Diagn Microbiol Infect Dis 27:151-154.
12. Potgieter E, Carmichael M, Koornhof HJ, Chalkey LJ (1992) In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis 11:543-546.
13. Salavert M, Gomez L, Rodriguez-Caballeira M, Xercavins M, Garau J (1996) Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis 15:365-371.
14. Venditti M, Baiocchi P, Santini C, Brandmarte A, Serra P, Gentile G, Girmenia C, Martino P (1989) Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. Antimicrob Agents Chemother 33:580-582.
15. Watanakunakorn C, Pantelakis J (1993) Alpha-hemolytic streptococcal bacteremia: A review of 203 episodes during 1980-1991. Scand J Infect Dis 25:403-408.